Paper39101201
Dapagliflozin Enhances Arterial and Venous Compliance During Exercise in Heart Failure With Preserved Ejection Fraction: Insights From the CAMEO-DAPA Trial.
Tada A and 11 others. Circulation, 2024. Cited by 37 papers, by iCite.
Cite this record
ConductScience Library. Dapagliflozin Enhances Arterial and Venous Compliance During Exercise in Heart Failure With Preserved Ejection Fraction: Insights From the CAMEO-DAPA Trial. Papers, record 39101201. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39101201
- Disease
- heart failure311 drugs
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Dapagliflozin Enhances Arterial and Venous Compliance During Exercise in Heart Failure With Preserved Ejection Fraction: Insights From the CAMEO-DAPA Trial.
- PubMed
Connected records1
Records in the library's other databases whose lists name this one, each read from that database's own release: up to 20 of each kind, the most connected first.
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Benzhydryl Compounds | Major topic |
| Glucosides | Major topic |
| Heart Failure | Major topic |
| Stroke Volume | Major topic |
| Sodium-Glucose Transporter 2 Inhibitors | Major topic |
| Exercise | Major topic |
| Humans | |
| Female | |
| Aged | |
| Male | |
| Middle Aged | |
| Compliance | |
| Hemodynamics | |
| Vascular Capacitance | |
| Exercise Test | |
| Blood Pressure |
Source PubMed
Grants15
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| K23 HL164901 | NHLBI NIH HHS | United States | K23HL164901 | PubMed | NIH RePORTER |
| R01 HL162828 | NHLBI NIH HHS | United States | R01HL162828 | PubMed and NIH | NIH RePORTER |
| R01 HL155599 | NHLBI NIH HHS | United States | R01HL155599 | PubMed and NIH | NIH RePORTER |
| R01 HL157108 | NHLBI NIH HHS | United States | R01HL157108 | PubMed and NIH | NIH RePORTER |
| K24 AG070459 | NIA NIH HHS | United States | K24AG070459 | PubMed and NIH | NIH RePORTER |
| R01 HL104106 | NHLBI NIH HHS | United States | R01HL104106 | PubMed and NIH | NIH RePORTER |
| R01 AG058969 | NIA NIH HHS | United States | R01AG058969 | PubMed and NIH | NIH RePORTER |
| R01 HL153646 | NHLBI NIH HHS | United States | R01HL153646 | PubMed and NIH | NIH RePORTER |
| U01 HL160277 | NHLBI NIH HHS | United States | U01HL160277 | PubMed and NIH | NIH RePORTER |
| R33 HL146390 | NHLBI NIH HHS | United States | R33HL146390 | PubMed and NIH | NIH RePORTER |
| U01 HL160226 | NHLBI NIH HHS | United States | U01HL160226 | PubMed and NIH | NIH RePORTER |
| UL1 TR001863 | NCATS NIH HHS | United States | UL1TR001863 | PubMed | NIH RePORTER |
| R01 HL155764 | NHLBI NIH HHS | United States | R01HL155764 | PubMed and NIH | NIH RePORTER |
| R01 HL128526 | NHLBI NIH HHS | United States | R01HL128526 | PubMed and NIH | NIH RePORTER |
| U01 TR003734 | NCATS NIH HHS | United States | U01TR003734 | PubMed and NIH | NIH RePORTER |
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT04730947 | Dapagliflozin (DAPA) Effects in HFpEF | Derived from the trial | Yes |
Source ClinicalTrials.gov
References43
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 17620524 | Acute and chronic ventricular-arterial coupling in systole and diastole: insights from an elderly hypertensive model. | Hypertension | 2007 | https://conductscience.org/library/papers/17620524 | PubMed |
| 2 | 28039229 | Role of Diastolic Stress Testing in the Evaluation for Heart Failure With Preserved Ejection Fraction: A Simultaneous Invasive-Echocardiographic Study. | Circulation | 2017 | https://conductscience.org/library/papers/28039229 | PubMed |
| 3 | 35512865 | Venous Tone and Stressed Blood Volume in Heart Failure: JACC Review Topic of the Week. | J Am Coll Cardiol | 2022 | https://conductscience.org/library/papers/35512865 | PubMed |
| 4 | 34743533 | Effect of Empagliflozin on Blood Volume Redistribution in Patients With Chronic Heart Failure and Reduced Ejection Fraction: An Analysis From the Empire HF Randomized Clinical Trial. | Circ Heart Fail | 2022 | https://conductscience.org/library/papers/34743533 | PubMed |
| 5 | 11641312 | Prospective evaluation of a method for estimating ascending aortic pressure from the radial artery pressure waveform. | Hypertension | 2001 | https://conductscience.org/library/papers/11641312 | PubMed |
| 6 | 33710924 | Personalized physiologic flow waveforms improve wave reflection estimates compared to triangular flow waveforms in adults. | Am J Physiol Heart Circ Physiol | 2021 | https://conductscience.org/library/papers/33710924 | PubMed |
| 7 | 24487087 | Effects of an interatrial shunt on rest and exercise hemodynamics: results of a computer simulation in heart failure. | J Card Fail | 2014 | https://conductscience.org/library/papers/24487087 | PubMed |
| 8 | 20733088 | Noninvasive evaluation of left ventricular afterload: part 2: arterial pressure-flow and pressure-volume relations in humans. | Hypertension | 2010 | https://conductscience.org/library/papers/20733088 | PubMed |
| 9 | 30764699 | Impact of Diabetes Mellitus on Ventricular Structure, Arterial Stiffness, and Pulsatile Hemodynamics in Heart Failure With Preserved Ejection Fraction. | J Am Heart Assoc | 2019 | https://conductscience.org/library/papers/30764699 | PubMed |
| 10 | 15699456 | Aortic diameter, aortic stiffness, and wave reflection increase with age and isolated systolic hypertension. | Hypertension | 2005 | https://conductscience.org/library/papers/15699456 | PubMed |
| 11 | 22003052 | Use of the Frank-Starling mechanism during exercise is linked to exercise-induced changes in arterial load. | Am J Physiol Heart Circ Physiol | 2012 | https://conductscience.org/library/papers/22003052 | PubMed |
| 12 | 37534453 | Cardiac and Metabolic Effects of Dapagliflozin in Heart Failure With Preserved Ejection Fraction: The CAMEO-DAPA Trial. | Circulation | 2023 | https://conductscience.org/library/papers/37534453 | PubMed |
| 13 | 30060748 | Glycemic control by the SGLT2 inhibitor empagliflozin decreases aortic stiffness, renal resistivity index and kidney injury. | Cardiovasc Diabetol | 2018 | https://conductscience.org/library/papers/30060748 | PubMed |
| 14 | 34053158 | Obesity, venous capacitance, and venous compliance in heart failure with preserved ejection fraction. | Eur J Heart Fail | 2021 | https://conductscience.org/library/papers/34053158 | PubMed |
| 15 | 14764438 | A novel framework of circulatory equilibrium. | Am J Physiol Heart Circ Physiol | 2004 | https://conductscience.org/library/papers/14764438 | PubMed |
| 16 | 27354047 | Abnormal right ventricular-pulmonary artery coupling with exercise in heart failure with preserved ejection fraction. | Eur Heart J | 2016 | https://conductscience.org/library/papers/27354047 | PubMed |
| 17 | 11498648 | Load dependent diastolic dysfunction in heart failure. | Heart Fail Rev | 2000 | https://conductscience.org/library/papers/11498648 | PubMed |
| 18 | 9950841 | Use of pulse pressure method for estimating total arterial compliance in vivo. | Am J Physiol | 1999 | https://conductscience.org/library/papers/9950841 | PubMed |
| 19 | 19114645 | Arthur C. Corcoran Memorial Lecture. Sympathetic activity, vascular capacitance, and long-term regulation of arterial pressure. | Hypertension | 2009 | https://conductscience.org/library/papers/19114645 | PubMed |
| 20 | 31466622 | Large-Artery Stiffness in Health and Disease: JACC State-of-the-Art Review. | J Am Coll Cardiol | 2019 | https://conductscience.org/library/papers/31466622 | PubMed |
Cited by27
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 37 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42866227 | Bidirectional metabolic-vascular feedback loops in heart failure: From myocardial energetics to multisystem cardiometabolic crosstalk. | iScience | 2026 | https://conductscience.org/library/papers/42866227 | PubMed |
| 42842573 | Using dapagliflozin to reduce symptoms in transthyretin cardiac amyloidosis: An n-of-1 trial series pilot study. | PLoS One | 2026 | https://conductscience.org/library/papers/42842573 | PubMed |
| 42770225 | Sotatercept Improves Right Heart Mechanics Despite Reduced Myocardial Contractility in Pulmonary Arterial Hypertension: A Prospective Exercise Hemodynamic Study. | Circulation | 2026 | https://conductscience.org/library/papers/42770225 | PubMed |
| 42518892 | Efficacy and Safety of SGLT2 Inhibitors and Sotagliflozin in Heart Failure: A Systematic Review and Meta-Analysis of 59 Randomized Controlled Trials. | Cureus | 2026 | https://conductscience.org/library/papers/42518892 | PubMed |
| 42291229 | Dapagliflozin binds PRMT7 to inhibit p38 MAPK phosphorylation and macrophage foam cell formation in atherosclerosis. | iScience | 2026 | https://conductscience.org/library/papers/42291229 | PubMed |
| 41888924 | Dapagliflozin-induced integrated improvements in left ventricular diastole, endothelial function, and arterial load: a randomized clinical trial. | Cardiovasc Diabetol | 2026 | https://conductscience.org/library/papers/41888924 | PubMed |
| 41711198 | Effect of sodium-glucose cotransporter-2 inhibitors on haemoglobin and haematocrit levels in heart failure: a systematic review and meta-analysis. | ESC Heart Fail | 2026 | https://conductscience.org/library/papers/41711198 | PubMed |
| 41685452 | Elevated Pulmonary Artery Wedge Pressure in Group 1 Pulmonary Hypertension. | Circulation | 2026 | https://conductscience.org/library/papers/41685452 | PubMed |
| 41682651 | Preserved Ejection, Lost Rhythm: A Narrative Review of the Pathophysiology and Management of Heart Failure with Preserved Ejection Fraction and Concomitant Atrial Fibrillation. | J Clin Med | 2026 | https://conductscience.org/library/papers/41682651 | PubMed |
| 41677477 | Progression From Exercise-Induced to Resting Left Atrial Hypertension in HFpEF: Impact of Reduced Atriopulmonary Compliance. | JACC Heart Fail | 2026 | https://conductscience.org/library/papers/41677477 | PubMed |
| 41528276 | Implications of Potential Undiagnosed HFpEF on Symptomatic Response With Coronary Revascularization. | JACC Heart Fail | 2026 | https://conductscience.org/library/papers/41528276 | PubMed |
| 41093487 | Do Heart Failure With Preserved Ejection Fraction Treatments Work by Targeting Adipose Biology? | J Am Coll Cardiol | 2025 | https://conductscience.org/library/papers/41093487 | PubMed |
| 41045908 | Semaglutide and Exercise Function in Obesity-Related HFpEF: Insights From the STEP-HFpEF Program. | JACC Heart Fail | 2025 | https://conductscience.org/library/papers/41045908 | PubMed |
| 40968746 | SGLT2 inhibitors for the prevention and treatment of heart failure: A scientific statement of the HFA and the HFAI. | ESC Heart Fail | 2025 | https://conductscience.org/library/papers/40968746 | PubMed |
| 40925989 | Evaluation of pulmonary hypertension in heart failure with preserved ejection fraction. | Heart Fail Rev | 2025 | https://conductscience.org/library/papers/40925989 | PubMed |
| 40886173 | The Adipokine Hypothesis of Heart Failure With a Preserved Ejection Fraction: A Novel Framework to Explain Pathogenesis and Guide Treatment. | J Am Coll Cardiol | 2025 | https://conductscience.org/library/papers/40886173 | PubMed |
| 40796340 | Visceral adiposity, aortic stiffness, and cardiovascular risk. | Eur J Prev Cardiol | 2026 | https://conductscience.org/library/papers/40796340 | PubMed |
| 40668525 | Determinants of exercise tolerance in HFpEF: role of the heart versus the periphery. | Heart Fail Rev | 2025 | https://conductscience.org/library/papers/40668525 | PubMed |
| 40608855 | Physiologic Phenotyping of Responses to Exercise and Activity in Heart Failure. | Circ Res | 2025 | https://conductscience.org/library/papers/40608855 | PubMed |
| 40521197 | BCAA catabolism targeted therapy for heart failure with preserved ejection fraction. | Theranostics | 2025 | https://conductscience.org/library/papers/40521197 | PubMed |
Drugs1
The drugs whose trials, in the Pipelines release, list the paper.
| Drug | ChEMBL ID | The trials list it as | Trials | In Drugs and targets |
|---|---|---|---|---|
| DAPAGLIFLOZIN | CHEMBL429910 | Derived from the trial | 1 | https://conductscience.org/library/drugs/CHEMBL429910 |
Source ChEMBL
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Comments and corrections
- Genes
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39101201
GET https://conductscience.org/api/papers/v1/39101201/references?page=2